塩の摂取量と血圧の変化

Expression of pulmonary vasoactive factors after sevoflurane anaesthesia in rats: a quantitative real-time polymerase chain reaction study.

British journal of anaesthesia·2007

A newly established strain of spontaneously hypertensive rat with a defect of ascorbic acid biosynthesis.

Life sciences·2001

AT1 receptor antagonist prevents brain edema without lowering blood pressure.

Acta neurochirurgica. Supplement·2001

Effects of inducible nitric oxide synthase inhibition on cerebral edema in severe hypertension.

Acta neurochirurgica. Supplement·2001

Role of angiotensin II type 1 receptor in the leucocytes and endothelial cells of brain microvessels in the pathogenesis of hypertensive cerebral injury.

Journal of hypertension·2001

Effects of the AT1 receptor antagonist on adhesion molecule expression in leukocytes and brain microvessels of stroke-prone spontaneously hypertensive rats.

American journal of hypertension·2000

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Assessing Knowledge, Attitudes, and Practices of Adults Aged 21-62 Regarding Antibiotic Use for Treatment of Upper Respiratory Tract Infections in Children: A multi-country Cross-Sectional Study.

Journal of preventive medicine and hygiene·2026

Stakeholder's experience on financial incentive-based regulatory instruments for public-private partnership in developing countries: a study from Iran's primary health care delivery system.

Primary health care research & development·2026

Turning policy implications into policy impact: Lessons from behavioral science in financial markets.

Proceedings of the National Academy of Sciences of the United States of America·2026

Policy text analysis of China's smart pharmaceutical regulation under a policy tool-policy stage framework.

Frontiers in public health·2026

Assessment of Physician Advocacy Engagement: A Scoping Review and Proposal of an Assessment Tool.

Journal of general internal medicine·2026

Factors influencing implementation decisions in health care: A discrete choice experiment of intervention adoption.

Healthcare (Amsterdam, Netherlands)·2026

関連する実験動画

塩の摂取量と血圧の変化

関連する概念動画

Expression of pulmonary vasoactive factors after sevoflurane anaesthesia in rats: a quantitative real-time polymerase chain reaction study.

A newly established strain of spontaneously hypertensive rat with a defect of ascorbic acid biosynthesis.

AT1 receptor antagonist prevents brain edema without lowering blood pressure.

Effects of inducible nitric oxide synthase inhibition on cerebral edema in severe hypertension.

Role of angiotensin II type 1 receptor in the leucocytes and endothelial cells of brain microvessels in the pathogenesis of hypertensive cerebral injury.

Effects of the AT1 receptor antagonist on adhesion molecule expression in leukocytes and brain microvessels of stroke-prone spontaneously hypertensive rats.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Assessing Knowledge, Attitudes, and Practices of Adults Aged 21-62 Regarding Antibiotic Use for Treatment of Upper Respiratory Tract Infections in Children: A multi-country Cross-Sectional Study.

Stakeholder's experience on financial incentive-based regulatory instruments for public-private partnership in developing countries: a study from Iran's primary health care delivery system.

Turning policy implications into policy impact: Lessons from behavioral science in financial markets.

Policy text analysis of China's smart pharmaceutical regulation under a policy tool-policy stage framework.

Assessment of Physician Advocacy Engagement: A Scoping Review and Proposal of an Assessment Tool.

Factors influencing implementation decisions in health care: A discrete choice experiment of intervention adoption.

関連する実験動画

塩の摂取量と血圧の変化

関連する概念動画

関連記事